pharmaphorum

OCTOBER 24, 2022

Exemptions include exceptional central procurements, centrally procured vaccines, small company sales, and low-value sales (when the NHS list price is less than £2). The PPRS changed over time, and the 2014 PPRS first introduced a cap to NHS branded medicines spending delivered via rebates. No mention of the CDF is in the annexes.

Vaccines 75

Vaccines 75

STAT

NOVEMBER 10, 2022

 But he was ousted in 2014 after an embarrassingly public conflict with the Sanofi board. At Sanofi, Viehbacher was largely responsible for repositioning the staid drugmaker and for deepening its partnership with Regeneron Pharmaceuticals. But Continue to STAT+ to read the full story…

Vaccines 219

Vaccines 219

Express Pharma

JANUARY 9, 2025

The data will serve as a foundation for cutting-edge research and will catalyse innovations in areas such as mRNA-based vaccines, protein manufacturing, and genetic disorder treatments. The Minister also pointed out that India is the largest vaccine producer in the world and the third-largest startup ecosystem.

Vaccines 105

Vaccines Hospitals 105

pharmaphorum

JANUARY 30, 2022

The debut was the largest IPO for a UK biotech company since allergy drug specialist Circassia in 2014, and followed a £195 million fundraising round for Oxford Nanopore in May. The Oxford University spin-out rose to prominence for commercialising the technology platform behind the Oxford/AstraZeneca COVID-19 vaccine.

Vaccines 98

Vaccines 98

pharmaphorum

FEBRUARY 14, 2022

In a recent report by Deloitte, however, the continual decline in return on R&D investment from 2014 was reversed in a minor way in 2020, followed by a significant improvement in 2021. As a result, the internal rate of return on investment is as high in 2021 as it has been across the industry since 2014. More than meets the eye.

Vaccines 98

Vaccines 98

pharmaphorum

JULY 14, 2021

In 2014, six years after the global financial crisis forced the world’s biggest financial institutions into some serious navel gazing, the CEO of a major international bank was despairing: “We’ve put in place a best-in-class compliance system, but we can’t stop our people acting badly.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

Pharmaceutical Technology

SEPTEMBER 5, 2022

Following AstraZeneca’s success in vaccine development during the Covid-19 pandemic , the pharmaceutical giant is now looking to expand its scope through acquisitions across a range of indications, says CEO Pascal Soriot. “We We want to be a sustainably growing company. billion in development.

Vaccines 114

Vaccines 114

Express Pharma

JULY 3, 2023

The Food and Drug Administration (FDA) approved an average of 43 drugs in 2014-18, compared to an average of 23 in the first decade of the century. Many millions of people are vaccinated against COVID-19, thanks to a messenger RNA (mRNA) encapsulated within a lipid nanoparticle.

Biosimilars 95

Biosimilars Drug Development Generic Medicine Diabetes 95

Express Pharma

OCTOBER 9, 2024

He noted that the number of biotech startups has risen from just 50 in 2014 to over 5,000 now, reflecting India’s increasing focus on bioeconomy. He stressed the need for proactive R&D, particularly in developing countermeasures for future pandemics, and the necessity of preparedness through rapid vaccine development.

Vaccines 105

Vaccines Process Improvement Biosimilars Immunization 105

European Pharmaceutical Review

JUNE 27, 2023

About the interviewees Hervé Affagard is the CEO and co-founder of MaaT Pharma, which was established in late 2014. He has also held the role of Vice President and Therapeutic Area Head, Vaccine Clinical Research at Merck & Co. For the past 15 years, Hervé has been an intra/entrepreneur in the healthcare industry.

Chemotherapy 105

Chemotherapy Immunization Immunity Vaccines 105

FDA Law Blog: Biosimilars

FEBRUARY 4, 2025

The Tropical Disease PRV program was born the very next year as part of the Food and Drug Administration Amendments Act of 2007 (FDAAA) and expanded in 2014 , which experts heralded as a game-changer for tropical disease therapies.

Vaccines 52

Vaccines 52

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 In April 2008, AstraZeneca also reached an agreement with Ranbaxy, an Indian generic drugmaker, allowing it to produce a generic version of Nexium starting in May 2014. Pfizer makes its move.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

Pharmaceutical Technology

JUNE 16, 2025

The US Food and Drug Administration (FDA) approved Amgen’s Blincyto (blinatumomab), the first bispecific T-cell engager (BiTE), in 2014 for adults with Ph- R/R B-ALL, with its label expanded in 2017 to include Ph+ and paediatric cases.

Labelling 52

Labelling Communication Hospitals Vaccines 52

European Pharmaceutical Review

JANUARY 29, 2024

Repurposing of currently marketed products, eg, methotrexate, 20 was an important and effective strategy in combatting COVID-19, particularly in the early stages prior to effective vaccines being developed. EMA initiatives for acceleration of development support and evaluation procedures for COVID-19 treatments and vaccines [OBSOLETE].

Drug Development 111

Drug Development Vaccines Compounding 111

pharmaphorum

OCTOBER 1, 2021

It also won a £113 million contract to provide rapid saliva-based COVID-19 testing services to the NHS, although that was ended early by the UK government in the summer as demand fell due to vaccinations.

Documentation 52

Documentation Vaccines 52

European Pharmaceutical Review

MARCH 1, 2023

Nowhere is this more publicly evident than in the development, regulatory approval, and efficacious use of mRNA‑based vaccines for COVID-19. Beyond the high-profile COVID-19 vaccines, mRNA therapeutics are crucial in applications such as protein replacement therapies and regenerative medicine. 2014 Nov 20; 56(4), 506‑17.

Vaccines 111

Vaccines Packaging 111

RX Note

APRIL 7, 2024

Consider HPV vaccination. The incubation period can be as long as 12 months. Strategies to reduce risk of transmission include Cover warts when they are being treated. Avoid sharing towels, shoes, or socks. They tend to be rough textured and usually less than 1 cm in diameter. Surgical removal (e.g.

Compounding 52

Compounding Immunization Immunity Community Pharmacies 52

pharmaphorum

JANUARY 21, 2022

And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccines, quickly followed by inequities in access. By 2016, Gilead already had competition for the HCV market, when MSD launched their product at €47,000 per treatment.

Vaccines 52

Vaccines 52

STAT

JANUARY 11, 2023

When I learned that an outbreak of Ebola was declared in Uganda last fall, I had a flashback to 2014 when I was working at Merck and an outbreak of Ebola disease caused by a different species of the virus emerged in full force in West Africa.

Vaccines 238

Vaccines 238

BioPharma Dive

JUNE 26, 2025

Hervé joined Incyte in 2014 when it was a single product, U.S.-only says US won’t donate to global vaccine effort View all Events 07 JUL Webinar | 10 a.m. questions vaccine evidence By Delilah Alvarado FDA investigating Elevidys safety; Nektar shares spike on eczema data By BioPharma Dive staff Cassidy challenges RFK Jr.

Drug Pricing 49

Drug Pricing Drug Development Vaccines 49

pharmaphorum

SEPTEMBER 9, 2021

COVID-19 also put global supply chains in the spotlight, as industry looked to remove obstacles and speed the delivery of material crucial to vaccine development processes. The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

PharmaShots

FEBRUARY 21, 2023

Under its cancer therapy products, the company develops low molecular drugs, antibody drugs, cancer peptide vaccines, and diagnostic medicines. Under its radiopharmaceutical segment, OncoTherapy is developing OTSA101, an anti-FZD10 antibody that specifically binds to FZD10 in cancer cells.

Dosage 56

Dosage Labelling Pharmaceutical Companies Immunization 56

PharmaShots

MAY 23, 2023

Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. Approved Cell and Gene Therapy: Collategene Founded Year: 1999 Total Employees: ~140 Headquarters: Osaka, Japan Market Cap: $162.8M

Pharmaceutical Companies 58

Pharmaceutical Companies Diabetes Immunization Immunity 58

PharmaTech

JUNE 23, 2025

FDA, USP Salt Policy (December 2014). 1, 2014 (accessed April 29, 2025). Recent Videos Related Content Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics Cheryl Barton June 24th 2025 Article mRNA technologies offer great promise in immunotherapy and non-immunogenic applications. YouTube.com , Dec.

Compounding 52

Compounding Dosage Labelling Drug Development 52

FDA Law Blog: Biosimilars

JANUARY 7, 2024

To better understand FDA’s approach in classifying postmarketing pregnancy studies as PMRs or PMCs, we reviewed all postmarketing requirements (PMRs) and postmarketing commitments (PMCs) related to maternal and fetal outcomes in FDA’s PMR/PMC database for drugs approved in the ten-year period from January 2014 through December 2023.

Documentation 59

Documentation Vaccines Drug Development 59

FDA Law Blog: Biosimilars

APRIL 7, 2025

Zenrelia comes with serious warnings, including a boxed warning against the use of Zenrelia during vaccination. CVM also objected to the truncation of other information about the timing of vaccines in these promotional materials. Zenrelia promotional materials also included claims about clinical data that the Agency found actionable.

Vaccines 64

Vaccines Adverse Reactions 64

PharmaTech

JUNE 6, 2025

A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. Analytical Validation (ICH, 2023). Easton, R.L. Structural Characterization Methods for Biosimilars: Fit-for-Purpose, Qualified, or Validated.

Dosage 52

Dosage Drug Development Documentation Biosimilars 52

pharmaphorum

MARCH 1, 2022

This was, and still is being, demonstrated through the UK’s COVID-19 vaccine research successes. She began her career in clinical research as a clinical trial assistant for Novartis Vaccines and Diagnostics in 2007 and continued to pursue her interest is vaccine research in 2014 when she joined GSK (formerly Novartis Vaccines).

Vaccines 96

Vaccines Hospitals 96

pharmaphorum

MAY 20, 2022

She began her career in clinical research as a clinical trial assistant for Novartis Vaccines and Diagnostics in 2007 and continued to pursue her interest is vaccine research in 2014 when she joined GSK (formerly Novartis Vaccines). Sheena has a wealth of experience of managing and delivering clinical trials.

Hospitals 59

Hospitals Medical Records Vaccines Diabetes 59

pharmaphorum

NOVEMBER 16, 2020

In his final message as head of the EMA, Rasi said the number of COVID-19 drugs and vaccines being developed by pharma companies is “encouraging,” and pointing to the agency’s pivotal role “in reviewing the available data packages to ensure that our usual high standards of safety, efficacy and quality are achieved and upheld.”.

Vaccines 64

Vaccines Packaging 64

Quality Matters

JUNE 13, 2023

Many regulatory authorities moved quickly to use emergency authority to approve new therapeutic treatments and vaccines for COVID-19. FDA issued the first emergency use authorization for a COVID-19 vaccine on Dec. For example, the U.S. 11, 2020, less than a year after WHO declared the coronavirus a global pandemic in March 2020.

Communication 52

Communication Vaccines 52

Quality Matters

JUNE 21, 2023

While WHO began assessing regulatory systems in 1997, work on the unified tool began in 2014 and it has subsequently incorporated various revisions in response to stakeholder feedback. Collecting real world safety data, including country-specific data, and information sharing was key to ensuring safety of COVID vaccines.”

Vaccines 52

Vaccines 52

pharmaphorum

APRIL 19, 2021

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. But Dix has also been leading the UK’s Vaccine Taskforce, after taking over the hot seat in December following the departure of Kate Bingham.

Vaccines 98

Vaccines 98

PharmaShots

APRIL 13, 2023

and became a leader in the medical device industry Novartis raised its sales by 16% and acquired Alcon (ophthalmic business), Genoptix (oncology business), and an 85% stake in Zhejiang Tianyuan (vaccine business) Bayer recorded a revenue of $49B as its pharmaceutical business posted an encouraging performance in the emerging market.

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

PharmExec

MARCH 13, 2024

Data shows that from 2014-2019, pneumococcal vaccinations in seniors increased by 10%, growing sales for Prevnar 13 due to government recommendation in addition to a high-profile advertising campaign.

Vaccines 52

Vaccines 52

PharmaShots

JANUARY 31, 2023

The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. Founded Year: 2014 No. Funding Value: $15.9M Founded Year: 2007 No. of Shares: 3.7M

Vaccines 40

Vaccines Immunization Immunity Diabetes 40

pharmaphorum

DECEMBER 21, 2020

Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against the COVID-19 scourge.

Vaccines 111

Vaccines Immunization Immunity 111